Novel mutations associated with combined pituitary hormone deficiency

Christopher J. Romero, Elyse Pine-Twaddell, Sally Radovick

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

The pituitary gland produces hormones that play important roles in both the development and the homeostasis of the body. A deficiency of two or several of these pituitary hormones, known as combined pituitary hormone deficiency, may present in infants or children due to an unknown etiology and is considered congenital or idiopathic. Advancements in our understanding of pituitary development have provided a genetic basis to explain the pathophysiological basis of pituitary hormone disease. Nevertheless, there are several challenges to the precise characterization of abnormal genotypes; these exist secondary to the complexities of several of the hypothalamic/pituitary developmental factors and signals, which ultimately integrate in a temporal and spatial dependent manner to produce a mature gland. Furthermore, the clinical presentation of pituitary hormone disease may be dynamic as subsequent hormone deficiencies may develop over time. The characterization of patients with mutations in genes responsible for pituitary development provides an opportunity to discover potential novel mechanisms responsible for pituitary pathophysiology. The focus of this review is to report the most recent mutations in genes responsible for pituitary development in patients with hypopituitarism and emphasize the importance to physicians and researchers for characterizing these patients. Continuing efforts toward understanding the molecular basis of pituitary development as well as genetic screening of patients with pituitary disease will offer new insights into both diagnostic and potential therapeutic options that will decrease the morbidity and mortality in patients with hypopituitarism.

Original languageEnglish (US)
Pages (from-to)R93-R102
JournalJournal of Molecular Endocrinology
Volume46
Issue number3
DOIs
StatePublished - Jun 1 2011

Fingerprint

Pituitary Diseases
Pituitary Hormones
Mutation
Hypopituitarism
Hormones
Genetic Testing
Pituitary Gland
Genes
Homeostasis
Genotype
Research Personnel
Combined Pituitary Hormone Deficiency
Morbidity
Physicians
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Endocrinology

Cite this

Romero, Christopher J. ; Pine-Twaddell, Elyse ; Radovick, Sally. / Novel mutations associated with combined pituitary hormone deficiency. In: Journal of Molecular Endocrinology. 2011 ; Vol. 46, No. 3. pp. R93-R102.
@article{24e33641e4b64bba8500c5c04d129cbf,
title = "Novel mutations associated with combined pituitary hormone deficiency",
abstract = "The pituitary gland produces hormones that play important roles in both the development and the homeostasis of the body. A deficiency of two or several of these pituitary hormones, known as combined pituitary hormone deficiency, may present in infants or children due to an unknown etiology and is considered congenital or idiopathic. Advancements in our understanding of pituitary development have provided a genetic basis to explain the pathophysiological basis of pituitary hormone disease. Nevertheless, there are several challenges to the precise characterization of abnormal genotypes; these exist secondary to the complexities of several of the hypothalamic/pituitary developmental factors and signals, which ultimately integrate in a temporal and spatial dependent manner to produce a mature gland. Furthermore, the clinical presentation of pituitary hormone disease may be dynamic as subsequent hormone deficiencies may develop over time. The characterization of patients with mutations in genes responsible for pituitary development provides an opportunity to discover potential novel mechanisms responsible for pituitary pathophysiology. The focus of this review is to report the most recent mutations in genes responsible for pituitary development in patients with hypopituitarism and emphasize the importance to physicians and researchers for characterizing these patients. Continuing efforts toward understanding the molecular basis of pituitary development as well as genetic screening of patients with pituitary disease will offer new insights into both diagnostic and potential therapeutic options that will decrease the morbidity and mortality in patients with hypopituitarism.",
author = "Romero, {Christopher J.} and Elyse Pine-Twaddell and Sally Radovick",
year = "2011",
month = "6",
day = "1",
doi = "10.1530/JME-10-0133",
language = "English (US)",
volume = "46",
pages = "R93--R102",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "3",

}

Novel mutations associated with combined pituitary hormone deficiency. / Romero, Christopher J.; Pine-Twaddell, Elyse; Radovick, Sally.

In: Journal of Molecular Endocrinology, Vol. 46, No. 3, 01.06.2011, p. R93-R102.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Novel mutations associated with combined pituitary hormone deficiency

AU - Romero, Christopher J.

AU - Pine-Twaddell, Elyse

AU - Radovick, Sally

PY - 2011/6/1

Y1 - 2011/6/1

N2 - The pituitary gland produces hormones that play important roles in both the development and the homeostasis of the body. A deficiency of two or several of these pituitary hormones, known as combined pituitary hormone deficiency, may present in infants or children due to an unknown etiology and is considered congenital or idiopathic. Advancements in our understanding of pituitary development have provided a genetic basis to explain the pathophysiological basis of pituitary hormone disease. Nevertheless, there are several challenges to the precise characterization of abnormal genotypes; these exist secondary to the complexities of several of the hypothalamic/pituitary developmental factors and signals, which ultimately integrate in a temporal and spatial dependent manner to produce a mature gland. Furthermore, the clinical presentation of pituitary hormone disease may be dynamic as subsequent hormone deficiencies may develop over time. The characterization of patients with mutations in genes responsible for pituitary development provides an opportunity to discover potential novel mechanisms responsible for pituitary pathophysiology. The focus of this review is to report the most recent mutations in genes responsible for pituitary development in patients with hypopituitarism and emphasize the importance to physicians and researchers for characterizing these patients. Continuing efforts toward understanding the molecular basis of pituitary development as well as genetic screening of patients with pituitary disease will offer new insights into both diagnostic and potential therapeutic options that will decrease the morbidity and mortality in patients with hypopituitarism.

AB - The pituitary gland produces hormones that play important roles in both the development and the homeostasis of the body. A deficiency of two or several of these pituitary hormones, known as combined pituitary hormone deficiency, may present in infants or children due to an unknown etiology and is considered congenital or idiopathic. Advancements in our understanding of pituitary development have provided a genetic basis to explain the pathophysiological basis of pituitary hormone disease. Nevertheless, there are several challenges to the precise characterization of abnormal genotypes; these exist secondary to the complexities of several of the hypothalamic/pituitary developmental factors and signals, which ultimately integrate in a temporal and spatial dependent manner to produce a mature gland. Furthermore, the clinical presentation of pituitary hormone disease may be dynamic as subsequent hormone deficiencies may develop over time. The characterization of patients with mutations in genes responsible for pituitary development provides an opportunity to discover potential novel mechanisms responsible for pituitary pathophysiology. The focus of this review is to report the most recent mutations in genes responsible for pituitary development in patients with hypopituitarism and emphasize the importance to physicians and researchers for characterizing these patients. Continuing efforts toward understanding the molecular basis of pituitary development as well as genetic screening of patients with pituitary disease will offer new insights into both diagnostic and potential therapeutic options that will decrease the morbidity and mortality in patients with hypopituitarism.

UR - http://www.scopus.com/inward/record.url?scp=79959513055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959513055&partnerID=8YFLogxK

U2 - 10.1530/JME-10-0133

DO - 10.1530/JME-10-0133

M3 - Review article

C2 - 21447626

AN - SCOPUS:79959513055

VL - 46

SP - R93-R102

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 3

ER -